REstart or STop Antithrombotic Randomised Trial in France "RESTART-Fr"


Phase 3 Results N/A

Summary of Purpose

RESTART- fr is a randomised controlled trial for adults surviving spontaneous intracerebral haemorrhage who had taken an antithrombotic drug (i.e. anticoagulant or antiplatelet medication) for the prevention of vaso-occlusive disease before the ICH. RESTART- fr is testing whether a policy of starting antiplatelet drugs (one or more of aspirin, clopidogrel, or dipyridamole, chosen at investigator's discretion)...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 May 2017.

7 Dec 2016 13 Jul 2016 1 Nov 2018 1 Nov 2019 1 May 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available


  • Hilde HENON, MD, PhD